A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of A Topical Estradiol Ophthalmic Formulation in Post-Menopausal Women With Moderate-To-Severe Dry Eye Disease

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.